共 50 条
- [42] Protein Biomarkers Identify Patients Unlikely to Benefit From Primary Prevention Implantable Cardioverter Defibrillators Findings From the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD) [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2014, 7 (06) : 1084 - U185
- [43] Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials [J]. HEART RHYTHM, 2016, 13 (07) : 1552 - 1559
- [44] Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (08): : 925 - 933
- [48] Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (11): : 1623 - 1630
- [49] The Benefit of a Second Burst Antitachycardia Sequence for Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (04): : 486 - 494